RT Journal Article
SR Electronic
T1 Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004850
DO 10.1136/jitc-2022-004850
VO 10
IS 11
A1 Cyr, Matthew G
A1 Mhibik, Maissa
A1 Qi, Junpeng
A1 Peng, Haiyong
A1 Chang, Jing
A1 Gaglione, Erika M
A1 Eik, David
A1 Herrick, John
A1 Venables, Thomas
A1 Novick, Scott J
A1 Courouble, Valentine V
A1 Griffin, Patrick R
A1 Wiestner, Adrian
A1 Rader, Christoph
YR 2022
UL http://jitc.bmj.com/content/10/11/e004850.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.